Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07168655 · ClinicalTrials.gov registry record
Mavacamten in Obstructive Hypertrophic Cardiomyopathy
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 163
- Enrollment target
NCT07168655 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 163 participants.
The verdict
NCT07168655 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the real-world outcomes of individuals diagnosed with obstructive hypertrophic cardiomyopathy (oHCM) treated with mavacamten at the Hospital of The University of Pennsylvania in the US
Interventions
- DRUG Mavacamten
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2023-02-21 |
| Est. Completion | 2025-03-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07168655
The ClinicalTrials.gov registry entry for NCT07168655 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mavacamten is the first listed.
NCT07168655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07168655 about?
NCT07168655 is a clinical study titled "Mavacamten in Obstructive Hypertrophic Cardiomyopathy". The purpose of this study is to evaluate the real-world outcomes of individuals diagnosed with obstructive hypertrophic cardiomyopathy (oHCM) treated with mavacamten at the Hospital of The University of Pennsylvania in the US
What is the current status of trial NCT07168655?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2023-02-21. Estimated completion is 2025-03-25.
What interventions are being tested in trial NCT07168655?
The interventions under investigation include: Mavacamten (DRUG).
Who is sponsoring clinical trial NCT07168655?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.